The legacy of Viagra and the pharmaceutical industry presents a challenging picture for prospective investors. Initially, copyright's remarkable drug transformed the treatment of erectile dysfunction, creating substantial profits and shaping the contemporary pharmaceutical landscape. However, intellectual property expiration and the rise of generic